Physician profile
Michael David Smith
NPI 1902835374
$1,094.56
in general payments reported to CMS, 2019-2025
18 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.27 · 2021: $40.37 · 2022: $50.74 · 2023: $490 · 2024: $199 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $319.24 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Boston Scientific Corporation | $225.03 | 2023-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Pfizer INC. | $149.74 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.79 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $43.23 | 2020-2021 | |
| Tempus Ai, INC | $41.51 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals Lp | $37.46 | 2023 | Enhertu, Imfinzi |
| 180 Medical, INC. | $21.47 | 2023 | Cure Catheter |
| Immunitybio, INC. | $20.93 | 2025 | |
| Abbvie INC. | $20.02 | 2024 | |
| Sumitomo Pharma America, INC. | $18.96 | 2025 | Orgovyx |
| Agios Pharmaceuticals, INC. | $18.02 | 2023 | Pyrukynd |
| Azurity Pharmaceuticals, INC. | $18.00 | 2025 | Vivimusta |
| Myriad Genetic Laboratories, INC. | $15.23 | 2023 | Myrisk |
| Janssen Biotech, INC. | $14.82 | 2025 | Erleada |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.04 | 2025 | Iclusig |
| Kyowa Kirin, INC. | $13.41 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.